ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,879, issued on July 15, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"Heterocyclic compound" was invented by Masashi Toyofuku (Kanagawa, Japan), Yoshiteru Ito (Kanagawa, Japan), Marilena Pira (Kanagawa, Japan) and Takahiro Sugimoto (Kanagawa, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound having a cell degeneration inhibitory action, particularly a motor neuron degeneration inhibitory action, which is useful as an agent for the prophylaxis or treatment of motor neuron diseases (e.g., amyotrophic lateral sclerosis, progressive bulbar paralysis, progressive muscular atrophy, primary lat...